Trials / Completed
CompletedNCT02364765
Assessment of Hematologic Parameters Before and After Bimaxillary Orthognathic Surgery
Assessment of Changes of Hematological Parameters and Need for Blood Transfusion in Bimaxillary Orthognathic Surgery
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 53 (actual)
- Sponsor
- Federal University of Minas Gerais · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the present study was to compare some hematologic parameters and operation time in patients who underwent esthetic bimaxillary surgery under hypotensive anesthesia.
Detailed description
Patients who underwent bimaxillary surgery were prospectively evaluated. Patients were divided into groups based on the surgical procedure and sex (predictor variables). Hemoglobin, red blood cells, hematocrit, and platelet were the primary outcome variables, operation time was the secondary outcome variable, and the patients' age and weight were the other variables.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remifentanil | Elective bimaxillary orthognathic surgery consisting of a unsegmented LeFort I osteotomy combined with a bilateral sagittal split osteotomy, under the influence of mean remifentanil administration of 0.3 mg/kg/hour |
Timeline
- Start date
- 2010-08-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2015-02-18
- Last updated
- 2015-02-18
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT02364765. Inclusion in this directory is not an endorsement.